LIPIX + NYCLIX Merge To form: Healthix

Congratulations on the merger! SV


Healthix™: A Tale of Two RHIOs


In a groundbreaking effort that provides clinicians with the means to significantly improve patient care throughout the region, the Long Island Patient Information eXchange (LIPIX) and the New York Clinical Information Exchange (NYCLIX) are proud to formally announce their plans to merge. The organizations, which were the two largest Regional Health Information Organizations (RHIOs) in the state, will unite to create Healthix, Inc. We are now one of the largest active, self-sustaining RHIOs in the country! The combining of our technologies, operations and governance expands and strengthens our leading health information exchange (HIE) services.


The Manhattan-based organization will have over 31 acute care hospitals, 24 long-term care providers, 14 home care agencies, and many other ambulatory practices among its 104 connected facilities. Additionally, the combined patient directory will represent nearly 2% of the United States’ population (over 5 million patients) and continues to grow daily.


Healthix will embrace a mission shared by both LIPIX and NYCLIX, as well as the state of New York, to deliver industry-leading, secure exchange of patient health information in support of collaborative care models, outcomes-based medicine, emerging reimbursement structures, and patient-driven healthcare. Benjamin Stein, MD, the CEO of LIPIX, and Gil Kuperman, MD, the Executive Director of NYCLIX, each addressed the news in a joint statement: “We are excited and proud that our two organizations could come together in a spirit of collaboration that should change the landscape of health information technology throughout the region and the country.” Dr. Stein, who will remain CEO of the combined entity, added, “The benefits of the enlarged organization and network will accrue to all of our current and future members; these cover the range from nationally renowned health systems to small rural independent practices. The biggest winners here, however, are the patients of New York.”

LIPIX